FilingReader Intelligence

Shilpa Medicare's Bengaluru unit receives favorable US FDA classification

July 16, 2025 at 04:49 AM UTCBy FilingReader AI

Shilpa Medicare Limited's Unit VI in Bengaluru received a Voluntary Action Indicated classification from the US FDA following a GMP inspection conducted from October 24-30, 2024.

The facility manufactures oral dissolving films and transdermal systems, and currently supplies oral film products to the US and other markets.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

BSE:SHILPAMEDBombay Stock Exchange

News Alerts

Get instant email alerts when Shilpa Medicare publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →